← Back to Search

Eye-Tracking for Word Learning in Deaf Children

N/A
Recruiting
Led By Amy Lieberman, PhD
Research Sponsored by Boston University Charles River Campus
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Deaf children ages 18-60 months born severely to profoundly deaf
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 10 seconds following experimenter prompt
Awards & highlights

Study Summary

This trial explores if deaf children learning sign language assume each object has one word ("mutual exclusivity"). It also explores if those learning both sign & spoken language demonstrate the same behavior.

Who is the study for?
This trial is for deaf children aged 18-60 months who were born with severe to profound hearing loss. It's suitable for those who use American Sign Language (ASL) and have normal or corrected-to-normal vision, regardless of whether their parents are deaf or hearing.Check my eligibility
What is being tested?
The study investigates how deaf children learn words using a principle called mutual exclusivity - the idea that each object has only one name. Researchers will see if this applies to kids learning ASL and those learning both ASL and spoken language through eye-tracking and behavior observation.See study design
What are the potential side effects?
Since this study involves observational methods like eye-tracking rather than medical interventions, there are no direct side effects associated with it. However, participation may involve typical discomforts from wearing eye-tracking equipment.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My child, aged 18-60 months, was born with severe to profound deafness.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~10 seconds following experimenter prompt
This trial's timeline: 3 weeks for screening, Varies for treatment, and 10 seconds following experimenter prompt for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Selected object

Trial Design

1Treatment groups
Experimental Treatment
Group I: Referential cues to objectExperimental Treatment1 Intervention
Each object pair that is presented to the child is accompanied by 1) gaze only (3 trials); 2) novel label only (3 trials); or 3) conflicting gaze and novel label (3 trials)

Find a Location

Who is running the clinical trial?

Boston University Charles River CampusLead Sponsor
114 Previous Clinical Trials
11,937 Total Patients Enrolled
1 Trials studying Hearing Loss
220 Patients Enrolled for Hearing Loss
Amy Lieberman, PhDPrincipal InvestigatorBoston University

Media Library

Referential cues to object Clinical Trial Eligibility Overview. Trial Name: NCT05993832 — N/A
Hearing Loss Research Study Groups: Referential cues to object
Hearing Loss Clinical Trial 2023: Referential cues to object Highlights & Side Effects. Trial Name: NCT05993832 — N/A
Referential cues to object 2023 Treatment Timeline for Medical Study. Trial Name: NCT05993832 — N/A
~27 spots leftby May 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top